companydata.dkPharmyn ApS: Financial statements 2023
CVR: 37133892
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 10,454 and a net result of DKK 10,429 compared with DKK -19,953 the year before. Equity amounted to DKK 24,370. The solvency ratio was 83.9%.
- Gross Profit
- 10,454 kr.
- Profit/Loss
- 10,429 kr.
- Equity
- 24,370 kr.
- Total Assets
- 29,057 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 10 t. | 10 t. | 24 t. | 0 |
| 2022 | - | -20 t. | -20 t. | 14 t. | 0 |
| 2021 | - | 12 t. | 12 t. | 34 t. | 0 |
| 2020 | - | -20 t. | -21 t. | 22 t. | 0 |
| 2019 | - | 108 | 0 | 42 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmyn ApS has published its annual report for 2022. Gross profit came to DKK -19,740, and the net result was DKK -19,953.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity amounted to DKK 18,662.